StopDownOpen the app

Funding · Healthcare & Life Sciences

FutureCure Health raises ₹104 crore for vertigo care

By ·

Date
Company
FutureCure Health
What it does
Vertigo diagnosis and treatment
Kind
Funding
Amount
₹104 crore ($11.5 million)
Founded
2015
Sector
Healthcare & Life Sciences

What they do

FutureCure Health is a healthcare technology company focused on super-speciality care

What happened

It raised ₹104 crore ($11.5 million) led by Carnelian Asset Management LLP

Why it matters

The company plans to expand vertigo diagnosis and treatment globally and into chronic conditions like migraine

The details

  • FutureCure Health raised ₹104 crore ($11.5 million) in a funding round.
  • The round was led by Carnelian Asset Management LLP with participation from other marquee investors.
  • The company will use the funds to expand access to vertigo diagnosis and treatment in India and globally.
  • It also plans to expand into chronic lifestyle conditions such as migraine and diabetes.
  • FutureCure Health's subsidiary NeuroEquilibrium is the world's largest chain of vertigo and dizziness clinics.
  • The company has over 300 clinics in India and 16 other countries.
  • It has diagnosed and treated over 150,000 patients.

The bigger picture

  • Vertigo and balance disorders affect nearly six crore people in India, many facing delayed or incorrect diagnoses.
  • The company's approach identifies the root cause of vertigo for targeted treatment, not symptom suppression.
  • Co-founder Anita Bhandari is a globally recognised expert in vertigo and balance disorders.

About the business

  • FutureCure Health is a healthcare technology company focused on super-speciality care.
  • Its wholly owned subsidiary NeuroEquilibrium operates the world's largest chain of vertigo and dizziness clinics.
  • The company integrates advanced diagnostic systems, cloud-based remote platforms, and deep-tech innovation.
  • It works with hospitals, ENT clinics, and neurology centres.
  • The company has over 300 clinics in India and 16 other countries.
  • It has served over 150,000 patients.
  • The technology enables precision neuro-otology care beyond urban centres.

The deal

Type
funding

Investors

  • Carnelian Asset Management LLP (lead)

Founders

  • Rajneesh Bhandari, co-founder
  • Anita Bhandari, co-founder

About FutureCure Health

Product
Super-speciality vertigo clinics and neuro-otology diagnostic and rehabilitation platforms through NeuroEquilibrium
Customers
Patients suffering from dizziness, vertigo, and balance disorders, as well as partner clinics and hospitals
How it makes money
Clinical diagnostic and rehabilitation treatment fees
What sets it apart
Root-cause diagnostic technology isolating inner ear, brain, or balance pathway issues for targeted care

Other articles talking about it

Read it as a card in the app

Same day

All startup news on 6 January 2026 →